GR3035918T3 - Method of coupling polysaccharides to proteins - Google Patents

Method of coupling polysaccharides to proteins

Info

Publication number
GR3035918T3
GR3035918T3 GR20010400772T GR20010400772T GR3035918T3 GR 3035918 T3 GR3035918 T3 GR 3035918T3 GR 20010400772 T GR20010400772 T GR 20010400772T GR 20010400772 T GR20010400772 T GR 20010400772T GR 3035918 T3 GR3035918 T3 GR 3035918T3
Authority
GR
Greece
Prior art keywords
chr
hydrogen
carbamoyl
integer
amino
Prior art date
Application number
GR20010400772T
Other languages
English (en)
Inventor
Peter Hoogerhout
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Publication of GR3035918T3 publication Critical patent/GR3035918T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Silicon Polymers (AREA)
  • Cooling Or The Like Of Semiconductors Or Solid State Devices (AREA)
GR20010400772T 1996-12-16 2001-05-22 Method of coupling polysaccharides to proteins GR3035918T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96203556A EP0848011B1 (en) 1996-12-16 1996-12-16 Method of coupling polysaccharides to proteins

Publications (1)

Publication Number Publication Date
GR3035918T3 true GR3035918T3 (en) 2001-08-31

Family

ID=8224703

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400772T GR3035918T3 (en) 1996-12-16 2001-05-22 Method of coupling polysaccharides to proteins

Country Status (12)

Country Link
US (1) US6361777B1 (el)
EP (1) EP0848011B1 (el)
JP (1) JP4619459B2 (el)
AT (1) ATE199908T1 (el)
AU (1) AU5347898A (el)
CA (1) CA2274852C (el)
DE (1) DE69612205T2 (el)
DK (1) DK0848011T3 (el)
ES (1) ES2156611T3 (el)
GR (1) GR3035918T3 (el)
PT (1) PT848011E (el)
WO (1) WO1998027107A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
IL165910A0 (en) * 2002-07-03 2006-01-15 Pericor Science Inc Compositions of hyaluronic acid and methods of use
EP2460813A1 (en) 2003-12-17 2012-06-06 Janssen Alzheimer Immunotherapy A beta immunogenic peptide carrier conjugates and methods of producing same
JP4764830B2 (ja) 2003-12-17 2011-09-07 ワイス・エルエルシー 免疫原性ペプチド担体コンジュゲートおよびその生産法
CN103816870B (zh) 2008-12-03 2016-11-23 株式会社钟化 含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
US9708413B2 (en) 2012-11-22 2017-07-18 Glytech, Inc. Glycosylated linker, compound containing glycosylated linker moiety and physiologically active substance moiety or salt thereof, and methods for producing said compound or salt thereof
WO2014084110A1 (ja) * 2012-11-30 2014-06-05 株式会社糖鎖工学研究所 糖鎖付加リンカー、糖鎖付加リンカーと生理活性物質とを含む化合物またはその塩、及びそれらの製造方法
US10668164B2 (en) 2014-02-14 2020-06-02 Pfizer Inc. Immunogenic glycoprotein conjugates
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549051B1 (fr) 1983-06-22 1986-05-16 Centre Nat Rech Scient Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
US4762713A (en) 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant
US5738855A (en) * 1994-10-17 1998-04-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Synthesis of typhoid fever vaccine from a plant or fruit polysaccharide

Also Published As

Publication number Publication date
ATE199908T1 (de) 2001-04-15
DK0848011T3 (da) 2001-07-16
WO1998027107A1 (en) 1998-06-25
DE69612205T2 (de) 2001-08-30
EP0848011A1 (en) 1998-06-17
AU5347898A (en) 1998-07-15
US6361777B1 (en) 2002-03-26
CA2274852A1 (en) 1998-06-25
JP2001509144A (ja) 2001-07-10
DE69612205D1 (de) 2001-04-26
EP0848011B1 (en) 2001-03-21
CA2274852C (en) 2008-06-17
PT848011E (pt) 2001-08-30
ES2156611T3 (es) 2001-07-01
WO1998027107A8 (en) 2000-01-20
JP4619459B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
GR3035918T3 (en) Method of coupling polysaccharides to proteins
ATE64396T1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ID22499A (id) Amida-amida asam n-(aril/heteroaril/alkilasetil) amino, komposisi farmasi yang terdiri dari amida asam amino tersebut, dan metode untuk menghambat pelepasan b-amiloid peptida dan/atau pembuatannya dengan menggunakan senyawa-senyawa tersebut
NZ542138A (en) Heterobifunctional polymeric bioconjugates
HUP0003690A2 (hu) Kamptotecinek polimer származékai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
NO950377D0 (no) Argatrobanopplösninger
AUPP268898A0 (en) High modulus polyurethane compositions
IL157816A0 (en) Steroids as agonists for fxr
NO20020725D0 (no) Celleadhesjonsinhibitorer
LV12350A (lv) Heptapeptida oksitocina analogi
BG101077A (en) New peptides
RU95112841A (ru) Полимерный конъюгат, способ его получения, производная 20-0-ациламинокамптотецина и способ ее получения, фармацевтическая композиция
NZ500990A (en) 20(S) camptothecin glycoconjugates
AU1930497A (en) Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
DK0720617T3 (da) Hidtil ukendte urethanholdige aminosteroidforbindelser
AU577206B2 (en) Conjugates of vinblastine and protein
MX9805061A (es) Preparacion estereoselectiva de derivados succinicos 2-substituidos.
NO980392L (no) Polyhydroksyalkylamidaminoksyder
WO2007054977A3 (en) Method and composition for skin depigmentation
NO961522L (no) Formaldehydfritt tverrbindingsmiddel for lakkbindemidler
KR970027045A (ko) 트리에틸렌테트라아민-14^c의 제조방법
FR2804957B1 (fr) Nouveaux derives de l'echinocandine, leur procede de preparation et leur application comme fongicides